{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:33:55Z","timestamp":1791999235665,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-MS-052"],"award-info":[{"award-number":["2024-MS-052"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbadis.2024.167555","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:18:26Z","timestamp":1731068306000},"page":"167555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["OTUD7B inhibited hepatic injury from NAFLD by inhibiting K48-linked ubiquitination and degradation of \u03b2-catenin"],"prefix":"10.1016","volume":"1871","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.bbadis.2024.167555_bb0005","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2024.167555_bb0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167555_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167555_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1499-3872(13)60021-1","article-title":"Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges","volume":"12","author":"Xiao","year":"2013","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"13","key":"10.1016\/j.bbadis.2024.167555_bb0030","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","article-title":"Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"21","author":"Takahashi","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0035","first-page":"19","article-title":"Current management of NAFLD","volume":"89","author":"Munteanu","year":"2016","journal-title":"Clujul Med"},{"key":"10.1016\/j.bbadis.2024.167555_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114764","article-title":"Ubiquitin pathways regulate the pathogenesis of chronic liver disease","volume":"193","author":"Park","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167555_bb0045","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1074\/jbc.M708690200","article-title":"NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling","volume":"283","author":"Enesa","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7437","key":"10.1016\/j.bbadis.2024.167555_bb0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature11831","article-title":"OTUD7B controls non-canonical NF-\u03baB activation through deubiquitination of TRAF3","volume":"494","author":"Hu","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167555_bb0055","first-page":"945","article-title":"RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway","volume":"13","author":"Chen","year":"2022"},{"key":"10.1016\/j.bbadis.2024.167555_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153426","article-title":"Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress","volume":"485","author":"Zhang","year":"2023","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167555_bb0065","first-page":"638","article-title":"Cezanne is a critical regulator of pathological arterial remodelling by targeting \u03b2-catenin signalling","volume":"118","author":"An","year":"2022"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167555_bb0070","first-page":"1686","article-title":"TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt\/\u03b2-catenin pathway","volume":"62","author":"Li","year":"2023"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167555_bb0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41419-023-05747-7","article-title":"USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through \u03b2-catenin stabilization","volume":"14","author":"Tang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164117738442","article-title":"Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases","volume":"15","author":"Ackers","year":"2018","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167555_bb0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.hbpd.2022.10.003","article-title":"Wnt\/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases","volume":"22","author":"Shree Harini","year":"2023","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.bbadis.2024.167555_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676644","article-title":"Transcriptional profiling of monocytes deficient in nuclear orphan receptors NR4A2 and NR4A3 reveals distinct signalling roles related to antigen presentation and viral response","volume":"12","author":"Phelan","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167555_bb0095","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2023.06.019","article-title":"Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2","volume":"79","author":"Li","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0100","first-page":"5969","article-title":"Intestinal FGF15\/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A","volume":"11","author":"Kim","year":"2020"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.289728.116","article-title":"The PIDDosome activates p53 in response to supernumerary centrosomes","volume":"31","author":"Fava","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2024.167555_bb0110","doi-asserted-by":"crossref","first-page":"40446","DOI":"10.1038\/srep40446","article-title":"Hypoxia activates Wnt\/\u03b2-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2024.167555_bb0115","doi-asserted-by":"crossref","first-page":"8162421","DOI":"10.1155\/2017\/8162421","article-title":"The role of tissue macrophage-mediated inflammation on NAFLD pathogenesis and its clinical implications","volume":"2017","author":"Alisi","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbadis.2024.167555_bb0120","first-page":"1","article-title":"Immunity as cornerstone of non-alcoholic fatty liver disease: the contribution of oxidative stress in the disease progression","volume":"22","author":"Dallio","year":"2021"},{"issue":"7654","key":"10.1016\/j.bbadis.2024.167555_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature22344","article-title":"TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling","volume":"545","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167555_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.20151426","article-title":"Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination","volume":"213","author":"Hu","year":"2016","journal-title":"J. Exp. Med."},{"issue":"43","key":"10.1016\/j.bbadis.2024.167555_bb0135","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1038\/onc.2011.587","article-title":"Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression","volume":"31","author":"Pareja","year":"2012","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbadis.2024.167555_bb0140","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/CIRCRESAHA.111.300119","article-title":"Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination","volume":"112","author":"Luong le","year":"2013","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167555_bb0145","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1161\/ATVBAHA.117.309249","article-title":"Mechanical activation of hypoxia-inducible factor 1\u03b1 drives endothelial dysfunction at Atheroprone sites","volume":"37","author":"Feng","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/agriculture12010105","article-title":"OTUD7A regulates inflammation- and immune-related gene expression in goose fatty liver","volume":"12","author":"Zhao","year":"2022","journal-title":"Agriculture"},{"key":"10.1016\/j.bbadis.2024.167555_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109266","article-title":"OTUD7B (Cezanne) ameliorates fibrosis after myocardial infarction via FAK-ERK\/P38 MAPK signaling pathway","volume":"724","author":"Zhang","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"issue":"24","key":"10.1016\/j.bbadis.2024.167555_bb0160","article-title":"Ovarian tumor domain-containing 7b attenuates pathological cardiac hypertrophy by inhibiting ubiquitination and degradation of Kr\u00fcppel-Like factor 4","volume":"12","author":"Du","year":"2023"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167555_bb0165","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0170","first-page":"481","article-title":"Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis","volume":"10","author":"Yoshioka","year":"2020"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167555_bb0175","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bbadis.2024.167555_bb0180","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/nu5020498","article-title":"Fat depots, free fatty acids, and dyslipidemia","volume":"5","author":"Ebbert","year":"2013","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167555_bb0185","doi-asserted-by":"crossref","first-page":"21240","DOI":"10.3390\/ijms141121240","article-title":"Lessons from mouse models of high-fat diet-induced NAFLD","volume":"14","author":"Nakamura","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167555_bb0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167555_bb0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167555_bb0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"6602","key":"10.1016\/j.bbadis.2024.167555_bb0205","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167555_bb0210","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167555_bb0215","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/MEG.0b013e3282f9b203","article-title":"Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease","volume":"20","author":"Morgan","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167555_bb0220","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.4238\/2015.April.10.1","article-title":"Role of APN and TNF-\u03b1 in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease","volume":"14","author":"Lin","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bbadis.2024.167555_bb0225","doi-asserted-by":"crossref","first-page":"41604","DOI":"10.1038\/srep41604","article-title":"Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167555_bb0230","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167555_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166913","article-title":"Exendin-4 inhibits hepatic lipogenesis by increasing \u03b2-catenin signaling","volume":"11","author":"Seo","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2024.167555_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.791861","article-title":"Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt\/\u03b2-catenin signal pathway","volume":"8","author":"Li","year":"2021","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167555_bb0245","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.21651","article-title":"WNT\/beta-catenin signaling in liver health and disease","volume":"45","author":"Thompson","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167555_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20091866","article-title":"Wnt signalling and the control of cellular metabolism","volume":"427","author":"Sethi","year":"2010","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167555_bb0255","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1096\/fj.02-1163fje","article-title":"Overexpression of c-myc in the liver prevents obesity and insulin resistance","volume":"17","author":"Riu","year":"2003","journal-title":"FASEB J."},{"issue":"21","key":"10.1016\/j.bbadis.2024.167555_bb0260","doi-asserted-by":"crossref","first-page":"30379","DOI":"10.18632\/oncotarget.8856","article-title":"Abnormal lipid processing but normal long-term repopulation potential of myc\u2212\/\u2212 hepatocytes","volume":"7","author":"Edmunds","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.bbadis.2024.167555_bb0265","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nsmb.1873","article-title":"Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne","volume":"17","author":"Bremm","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7625","key":"10.1016\/j.bbadis.2024.167555_bb0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature19836","article-title":"Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne","volume":"538","author":"Mevissen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167555_bb0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"16","key":"10.1016\/j.bbadis.2024.167555_bb0280","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.molimm.2009.07.019","article-title":"Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis","volume":"46","author":"Aherne","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbadis.2024.167555_bb0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2017.00007","article-title":"NR4A receptors differentially regulate NF-\u03baB signaling in myeloid cells","volume":"8","author":"McEvoy","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924005490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924005490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:29:28Z","timestamp":1768354168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924005490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0925443924005490"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167555","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OTUD7B inhibited hepatic injury from NAFLD by inhibiting K48-linked ubiquitination and degradation of \u03b2-catenin","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167555"}}